Breakthrough Technologies for Optogenetics

  • Lightweight
  • Battery Free
  • Implantable
  • Ultraminiaturized

NeuroLux News

posted: 2018-01-31

Latest Development of an Upcoming Addition to Our Product Portfolio Published in PNAS!

Wireless optogenetics technology for neuroscience research has assisted the neuroscience community in controlling neural activation and silencing and catalyzed a desire for powerful synergistic tools. One of the latest advancement in complementary toolsets is the creation of fiber photometry, with capability to optically record neural activity. The currently-available tethered approach imposes physical constraints that restrict […]

posted: 2017-10-19

NeuroLux awarded NIH STTR Phase I Grant

NeuroLux, an early stage biotech company based in Champaign, IL, has been awarded a Small Business Technology Transfer (STTR) Phase I grant by the National Institutes of Health (NIH) to develop wireless, battery-free devices for programmable fluid delivery and optogenetic stimulation, in designs fully compatible with the existing NeuroLux HF wireless electronic platform and control […]

posted: 2017-10-11

NeuroLux Spinal Optogenetics System Published in PAIN!

This new wireless platform that adapts near-field communication (NFC) technology and microscale LED technologies for optogenetic studies beyond the brain. The reported devices are designed specifically for implantation in a minimally invasive fashion over the mouse spinal cord for wireless and battery-free optogenetic interrogation of spinal circuits in freely moving animals. The studies utilized NeuroLux […]

Full News Archive

Recent Publications

Fully implantable, battery-free wireless optoelectronic devices for spinal optogenetics.

V. K Samineni, et al, 2017

The Journal of the International Association for the Study of Pain

Full Publications Archive